| Segment | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|
| Amtagvi | $42.04M | $48.71M | $43.57M | $54.07M | $57.48M | $64.9M | $60.22M | $90.72M |
| Proleukin | $16.52M | $24.98M | $5.75M | $5.88M | $9.97M | $21.87M | $11.21M | $8.59M |
| Total | $58.56M | $73.69M | $49.32M | $59.95M | $67.46M | $86.77M | $71.43M | $99.31M |
